Virbac SA Valuation
| VIRP Stock | EUR 324.50 4.00 1.22% |
At this time, the company appears to be overvalued. Virbac SA has a current Real Value of €282.32 per share. The regular price of the company is €324.5. Our model measures the value of Virbac SA from inspecting the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 8.44 M, and Return On Equity of 0.15 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Virbac SA's price fluctuation is very steady at this time. Calculation of the real value of Virbac SA is based on 3 months time horizon. Increasing Virbac SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Virbac SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Virbac Stock. However, Virbac SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 324.5 | Real 282.32 | Hype 324.5 | Naive 322.72 |
The real value of Virbac Stock, also known as its intrinsic value, is the underlying worth of Virbac SA Company, which is reflected in its stock price. It is based on Virbac SA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Virbac SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Virbac SA helps investors to forecast how Virbac stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Virbac SA more accurately as focusing exclusively on Virbac SA's fundamentals will not take into account other important factors: Virbac SA Total Value Analysis
Virbac SA is at this time forecasted to have takeover price of 2 B with market capitalization of 2.4 B, debt of 13.15 M, and cash on hands of 63.55 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Virbac SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2 B | 2.4 B | 13.15 M | 63.55 M |
Virbac SA Investor Information
About 50.0% of the company outstanding shares are owned by insiders. The book value of Virbac SA was at this time reported as 96.99. The company recorded earning per share (EPS) of 14.05. Virbac SA last dividend was issued on the 24th of June 2022. The entity had 4:1 split on the 30th of July 2002. Based on the key measurements obtained from Virbac SA's financial statements, Virbac SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Virbac SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Virbac SA has an asset utilization ratio of 88.55 percent. This suggests that the Company is making €0.89 for each dollar of assets. An increasing asset utilization means that Virbac SA is more efficient with each dollar of assets it utilizes for everyday operations.Virbac SA Ownership Allocation
The market capitalization of Virbac SA is €2.4 Billion. Virbac SA maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Virbac SA Profitability Analysis
The company reported the revenue of 1.06 B. Net Income was 113.16 M with profit before overhead, payroll, taxes, and interest of 712.85 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Virbac SA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Virbac SA and how it compares across the competition.
About Virbac SA Valuation
The stock valuation mechanism determines Virbac SA's current worth on a weekly basis. Our valuation model uses a comparative analysis of Virbac SA. We calculate exposure to Virbac SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Virbac SA's related companies.Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people.
8 Steps to conduct Virbac SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Virbac SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Virbac SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Virbac SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Virbac SA's revenue streams: Identify Virbac SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Virbac SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Virbac SA's growth potential: Evaluate Virbac SA's management, business model, and growth potential.
- Determine Virbac SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Virbac SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Virbac Stock analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |